05/03/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/03/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/23/2024
3:05 PM | AlloVir (Filer)
| Form DEF 14A | |
04/23/2024
3:06 PM | AlloVir (Filer)
| Form DEFA14A | |
04/23/2024
3:08 PM | AlloVir (Filer)
| Form ARS | |
|
04/23/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/23/2024
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/04/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2024
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
6:30 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
6:30 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
6:30 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/02/2024
6:30 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024
7:43 AM | AlloVir (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:16 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/22/2024
3:18 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
7:22 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
4:30 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
4:30 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
4:30 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
3:30 PM | AlloVir (Filer)
| Form RW | |
02/09/2024
7:01 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:12 PM | AlloVir (Subject)
Artal International S.C.A. (Filed by)
| Form SC 13G/A | |
02/09/2024
7:35 AM | AlloVir (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/08/2024
4:01 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024
3:38 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
3:39 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Next Nvidia? (Ad) The Next Nvidia?
Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about. Go here now for this breaking story. |
02/06/2024
3:40 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2024
3:46 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
7:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
7:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
7:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/05/2024
7:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/01/2024
4:11 PM | AlloVir (Subject)
EcoR1 Capital, LLC (Filed by)
| Form SC 13G | |
01/23/2024
7:30 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
7:30 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
7:30 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2024
7:30 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/09/2024
11:32 AM | AlloVir (Subject)
Wilson John Robert (Filed by)
| Form SC 13G/A | |
01/09/2024
11:29 AM | AlloVir (Subject)
Wilson John Robert (Filed by)
| Form SC 13G | |
01/08/2024
3:15 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:15 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:15 PM | AlloVir (Issuer)
Miller Edward (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:15 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
5:00 PM | AlloVir (Subject)
Miller Edward (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
5:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
4:21 PM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
6:36 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/22/2023
6:07 AM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/17/2023
4:30 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
4:30 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/17/2023
4:30 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
7:11 AM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
4:00 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
4:00 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
4:00 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/20/2023
4:20 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/20/2023
4:29 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
4:00 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
4:00 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/19/2023
4:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/05/2023
4:00 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:00 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/05/2023
4:00 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
4:56 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023
4:49 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2023
4:50 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/18/2023
4:00 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
4:07 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/17/2023
4:10 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/03/2023
6:34 AM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2023
6:23 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023
6:17 PM | AlloVir (Subject)
Hagen Brett R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/19/2023
5:51 PM | AlloVir (Subject)
Sinha Vikas (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/06/2023
4:00 PM | AlloVir (Issuer)
Sinha Vikas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Next Nvidia? (Ad) The Next Nvidia?
Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about. Go here now for this breaking story. |
07/06/2023
4:00 PM | AlloVir (Issuer)
Brainard Diana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
4:49 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2023
4:17 PM | AlloVir (Issuer)
GILEAD SCIENCES, INC. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2023
3:14 PM | AlloVir (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/22/2023
4:15 PM | AlloVir (Filer)
| Form 424B5 | |
06/21/2023
4:29 PM | AlloVir (Filer)
| Form 424B5 | |
06/21/2023
4:00 PM | AlloVir (Issuer)
Piccina Cintia (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/13/2023
4:00 PM | AlloVir (Issuer)
Hagen Brett R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
7:29 PM | AlloVir (Subject)
Brainard Diana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
